SK bioscience is stepping up work on a nasal spray to prevent and treat COVID-19. With the Bill & Melinda Gates Foundation kicking in cash, the Korean biotech is preparing for initial process R&D for ...
REPORTING ON THIS ISSUE SINCE MAY. YEAH. AND HERE’S A QUICK TIMELINE IN MAY, THE FIRST TWO MARYLAND RESIDENTS REACHED OUT, SAYING THAT THEIR MEDICARE NUMBERS WERE CHARGED FOR UNWANTED COVID TESTS.
SK Bioscience made a major score last week when it unveiled a lucrative coronavirus vaccine deal with Novavax. Just six days later, SK announced a plan that ups the ante—to the tune of $900 million.
March 21 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by ...
SK bioscience to manufacture antigen component of NVX-CoV2373 Builds on and complements Novavax-CEPI collaboration to develop and distribute NVX-CoV2373 Novavax, SK bioscience and Republic of Korea ...
SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine ...
GlaxoSmithKline plc GSK, along with Korean biopharmaceutical company SK bioscience, announced that they have initiated a phase III study on the latter’s nanoparticle COVID-19 vaccine candidate, GBP510 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback